Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer's disease and vascular dementia

Neurobiology of Aging

Volumn 23, Issue 2, 2002, Pages 237-243

  Tarkowski, Elisabeth ^a   Issa, Razao ^b   Sjögren, Magnus ^a   Wallin, Anders ^a   Blennow, Kaj ^a   Tarkowski, Andrej ^a   Kumar, Pat ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Angiogenesis; Cerebrospinal fluid; Cytokines; TGF , Dementia; VEGF

Indexed keywords

AMYLOID BETA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ALZHEIMER DISEASE; ANGIOGENESIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AGED; ALBUMINS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DEMENTIA, VASCULAR; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036167595     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00285-8     Document Type: Article

References (42)

1. The vascular endothelial growth factor family; proteins which guide the development of the vasculature
2. Cerebrospinal fluid β-amyloid in Alzheimer disease: Differences between early- and late onset Alzheimer disease and stability during the course of the disease
3. Alzheimer's disease
4. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-β
5. Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and IL-10
6. White-matter lesions on CT in Alzheimer patients: Relation to clinical symptomatology and vascular factors
7. Transforming growth factor-β is in Alzheimer's disease
8. Altered expression of transforming growth factor-β in Alzheimer's disease
9. Expression of intercellullar adhesion molecule 1 (ICAM-1) in Alzheimer's disease
10. A new rating scale for dementia syndromes
11. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease
12. White matter changes: Symptoms and signs
13. Neuropathology of the small blood vessels in selected diseases of the cerebal white matter
14. Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
15. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia
16. Cerebral vessels in aging and Alzheimer's disease
17. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro
18. Diagnostic accuracy of Alzheimer's disease: A neuropathological study
19. Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans
20. TGF-β receptors-I and -II immunoexpression in Alzheimer's disease: A comparison with ageing and progressive supranuclear palsy
21. Proinflammatory mediators stimulate neutrophil-directed angiogenesis
22. Differential expression of TGF-β1, 2 and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, in aged human and mouse control brains
23. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease
24. Mechanism of angiogenesis in the brain
25. TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases
26. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-ARIEN International workshop
27. Disorders of psychic function. Dementia
28. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
29. Brain infarction and the clinical expression of Alzheimer's disease. The nun study
30. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro
31. TNF gene polymorphism and its relation to intracerebral production of TNF-α and -β in AD
32. Intrathecal release of pro- and anti-inflammatory cytokines in stroke
33. Local production of TNF-α, a potent neuroprotective agent, in Alzheimer's disease and vascular dementia
34. Vascular endothelial growth factor, a potent and selective angiogenic agent
35. Tumor necrosis factor (TNF)
36. Decreased lumbar CSF levels of monoamine metabolites in vascular dementia
37. Research criteria for clinical diagnosis of "pure" Alzheimers disease
38. The clinical diagnosis of vascular dementia
39. The pathogenetic basis of vascular dementia
40. Transforming growth factor-β1 is in plaques in Alzheimer's and down pathologies
41. Development of a specific diagnostic test for the measurement of β-amyloid in CSF
42. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease